{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:49:37Z","timestamp":1778759377593,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.109876","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T10:23:01Z","timestamp":1590315781000},"page":"109876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application"],"prefix":"10.1016","volume":"144","author":[{"given":"Carlo","family":"Contini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Enrica Gallenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampiero","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Maritati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2020.109876_b0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000276031","article-title":"Bacterial flora in the nasopharynx and nasal cavity of healthy young men","volume":"51","author":"Ylikoski","year":"1989","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.mehy.2020.109876_b0010","unstructured":"Institute for Clinical Systems Improvement. Healthcare guideline: acute pharyngitis, general implementation. Bloomington, MN; 2000. Available from:www.icsi.org."},{"key":"10.1016\/j.mehy.2020.109876_b0015","unstructured":"Barbini P. Misure dell\u2019apparato respiratorio. Appunti. Publichealth.it\/wp-content\/uploads\/2016\/06MISURE-RESPIRATORIE-Medicina.pdf."},{"key":"10.1016\/j.mehy.2020.109876_b0020","article-title":"Strumentazione Biomedica","author":"Webster","year":"2010","journal-title":"EdiSES"},{"key":"10.1016\/j.mehy.2020.109876_b0025","first-page":"901","article-title":"Ocular surface temperature","volume":"8","author":"Efron","year":"1989","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.mehy.2020.109876_b0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0141-7037(96)80018-8","article-title":"Ocular surface cooling in dry eye a pilot study","volume":"19","author":"Morgan","year":"1996","journal-title":"J British Contact Lens Ass"},{"key":"#cr-split#-10.1016\/j.mehy.2020.109876_b0035.1","doi-asserted-by":"crossref","unstructured":"a). Sun X, Zhang X, Chen X, Chen L, Deng CH, et al. The infection evidence of SARS-COV-2 in ocular surface: a single-center cross-sectional study. February 2020. MedRxiv preprint. doi :10.1101\/2020.02.26.20027938","DOI":"10.1101\/2020.02.26.20027938"},{"key":"#cr-split#-10.1016\/j.mehy.2020.109876_b0035.2","doi-asserted-by":"crossref","unstructured":"b). Chen L, Deng CH, ChenX, Zhang X, Chen B, et al. Ocular manifestations and clinical characteristics of 534 cases of COVID-19 in China: A cross-sectional study. March 2020. MedRxiv preprint. doi: 10.1101\/2020.03.12.20034678.","DOI":"10.1111\/aos.14472"},{"issue":"18","key":"10.1016\/j.mehy.2020.109876_b0040","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.109876_b0045","doi-asserted-by":"crossref","DOI":"10.1111\/aos.14413","article-title":"There may be virus in conjunctival secretion of patients with COVID-19","author":"Liang","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.mehy.2020.109876_b0050","article-title":"Spread of respiratory viruses: Temperature and physical environment temperature control may exploit virus hypo- thermolability. A possible, immediate solution for COVID-19. Med","volume":"5","author":"Belcaro","year":"2020","journal-title":"Clin Res"},{"issue":"2","key":"10.1016\/j.mehy.2020.109876_b0055","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV- 2): anti-inflammatory strategies","volume":"32","author":"Conti","year":"2020","journal-title":"J Biol Homeost Agents"},{"key":"10.1016\/j.mehy.2020.109876_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-2019)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.mehy.2020.109876_b0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan","author":"Shi","year":"2020","journal-title":"Cina. JAMA Cardiol."},{"key":"10.1016\/j.mehy.2020.109876_b0070","article-title":"Novel coronavirus infection and gastrointestinal tract","volume":"2020","author":"Gao","year":"2019","journal-title":"J Dig Dis"},{"key":"10.1016\/j.mehy.2020.109876_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00124784-200505000-00005","article-title":"SARS: mobilizing and maintaining a public health emergency response","volume":"1","author":"Posid","year":"2005","journal-title":"J Public Health Manag Pract"},{"key":"10.1016\/j.mehy.2020.109876_b0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/2049-632X.12166","article-title":"The emergence of the Middle East respiratory syndrome coronavirus","volume":"7","author":"Milne-Price","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.mehy.2020.109876_b0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3855\/jidc.12671","article-title":"The novel zoonotic COVID-19 pandemic: an expected global health concern","volume":"14","author":"Contini","year":"2020","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.mehy.2020.109876_b0090","doi-asserted-by":"crossref","unstructured":"van Doremalen N, Bushmaker T,Morris D, Holbrook M, Gamble A, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1.NEJM doi:10.1056\/NEJMc2004973.","DOI":"10.1056\/NEJMc2004973"},{"key":"10.1016\/j.mehy.2020.109876_b0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1090-0233(03)00083-2","article-title":"Feline coronavirus \u2013 that enigmatic little critter","volume":"167","author":"Addie","year":"2004","journal-title":"Vet J"},{"key":"10.1016\/j.mehy.2020.109876_b0100","doi-asserted-by":"crossref","unstructured":"Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2 NS Neurosci Ther 2020 Apr 7. doi: 10.1111\/cns.13372.","DOI":"10.1111\/cns.13372"},{"key":"10.1016\/j.mehy.2020.109876_b0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109876_b0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/vr.m740","article-title":"Where did SARS-CoV-2 come from?","volume":"186","author":"Zhai","year":"2020","journal-title":"Vet Rec"},{"key":"10.1016\/j.mehy.2020.109876_b0115","doi-asserted-by":"crossref","unstructured":"Wang C,Li W, Drabek D, et al. A human monoclonal antibody blocking SARS-CoV-2 infection.bioRxiv. 2020.doi: 10.1101\/2020.03.11.987958.","DOI":"10.1101\/2020.03.11.987958"},{"key":"10.1016\/j.mehy.2020.109876_b0120","doi-asserted-by":"crossref","first-page":"eaax8756","DOI":"10.1126\/sciimmunol.aax8756","article-title":"Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties","volume":"5","author":"Bb","year":"2020","journal-title":"Sci Immunol"},{"issue":"19","key":"10.1016\/j.mehy.2020.109876_b0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of Lopinavir\u2013Ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.109876_b0130","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antiviral Res"},{"issue":"19","key":"10.1016\/j.mehy.2020.109876_b0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMe2005477","article-title":"Covid-19 \u2014 the search for effective therapy","volume":"382","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.mehy.2020.109876_b0140","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically Ill patients with COVID-19 with Convalescent Plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.109876_b0145","unstructured":"Paglia S. Lesson on SARS \u2013CoV-2 clinical phenotypes. Hospital Emergency Dept, Lodi, Italy. Shared with Wuhan doctors, March 16th, 2020."},{"key":"10.1016\/j.mehy.2020.109876_b0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5195","article-title":"Evaluating the placebo status of nebulized normal saline in patients with acute viral bronchiolitis: a systematic review and meta-analysis","author":"House","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.mehy.2020.109876_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S1806-83242007000500005","article-title":"The effect of mouthrinses against oral microorganisms","volume":"21","author":"Cortelli","year":"2007","journal-title":"Braz Oral Res"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2020.109876_b0160","first-page":"29","article-title":"Inactivation of human viruses by Povidone-iodine in comparison with other antiseptics","volume":"195","author":"Kitamura","year":"1997","journal-title":"Dermatology"},{"issue":"10223","key":"10.1016\/j.mehy.2020.109876_b0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109876_b0170","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"2020","author":"Sheahan","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mehy.2020.109876_b0175","unstructured":"Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2). NCT00886353, 2019."},{"key":"10.1016\/j.mehy.2020.109876_b0180","unstructured":"APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19. PipelineReview.com 2 April 2020."},{"key":"10.1016\/j.mehy.2020.109876_b0185","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like receptors and type I interferons","volume":"282","author":"Uematsu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2020.109876_b0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2-mesenchimal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.mehy.2020.109876_b0195","first-page":"12","article-title":"Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections","volume":"31","author":"Zhavoronkov","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.mehy.2020.109876_b0200","doi-asserted-by":"crossref","unstructured":"Gralinski LE,Sheahan TP,Morrison TE,Menachery VD3,Jensen K, et al. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio2018; Oct 9;9(5). pii: e01753\u201318. doi: 10.1128\/mBio.01753-18.","DOI":"10.1128\/mBio.01753-18"},{"issue":"4","key":"10.1016\/j.mehy.2020.109876_b0205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2020.01.010","article-title":"Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients","volume":"80","author":"Hansen","year":"2020","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.mehy.2020.109876_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2017.10.016","article-title":"Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis","volume":"76","author":"Lee","year":"2018","journal-title":"J. Infect."},{"key":"10.1016\/j.mehy.2020.109876_b0215","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad- spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Translat Med"},{"key":"10.1016\/j.mehy.2020.109876_b0220","doi-asserted-by":"crossref","unstructured":"Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. NEJM April 10, 2020. DOI: 10.1056\/NEJMoa2007016.","DOI":"10.1056\/NEJMoa2007016"},{"key":"10.1016\/j.mehy.2020.109876_b0225","unstructured":"World Health Organisation (WHO). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html."},{"key":"10.1016\/j.mehy.2020.109876_b0230","unstructured":"Cerullo M. Gilead suspends emergency access to experimental coronavirus drug remdesivir.CBS News. Retrieved23 March2020."},{"key":"10.1016\/j.mehy.2020.109876_b0235","unstructured":"Ferguson NM, Laydon D, Nedjati-Gilani GM, Natsuko I, Kylie A, et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College of Science, Technology and Medicine: 20. Retrieved 22 March 2020."},{"issue":"2","key":"10.1016\/j.mehy.2020.109876_b0240","article-title":"How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"10.1016\/j.mehy.2020.109876_b0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.mehy.2020.109876_b0250","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.23812\/Editorial","article-title":"Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity","volume":"33","author":"Franza","year":"2019","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.mehy.2020.109876_b0255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5301\/ejo.5000964","article-title":"Povidone-iodine 3-minute exposure time is viable in preparation for cataract surgery","volume":"27","author":"Nguyen","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.mehy.2020.109876_b0260","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.survophthal.2018.05.002","article-title":"Povidone-iodine concentration and dosing in cataract surgery","volume":"63","author":"Koerner","year":"2018","journal-title":"Surv Ophthalmol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720309518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720309518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:24:09Z","timestamp":1759692249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720309518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":53,"alternative-id":["S0306987720309518"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109876","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109876"}}